22:42 , May 21, 2019 |  BioCentury  |  Finance

Debt and equity investor K2HV seeks ‘profit and purpose’ in $400M launch

Newly launched venture debt and equity investor K2 HealthVentures says it will redirect some of its returns to “underserved and underinvested” areas of the life sciences and healthcare sphere as it invests the first $400...
01:01 , Jan 31, 2018 |  BC Extra  |  Company News

Amazon, Berkshire, JPM healthcare deal rocks incumbents

Leading managed care organizations (MCOs), drug distributors and retailers lost more than $32 billion combined in market cap Tuesday on the news that Amazon.com Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK-A; NYSE:BRK-B) and JPMorgan Chase &...
05:09 , Nov 17, 2017 |  BC Week In Review  |  Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
22:39 , Nov 15, 2017 |  BC Extra  |  Company News

Cardinal Health sells China distribution business to Shanghai Pharma

Cardinal Health Inc. (NYSE:CAH) sold its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co. Ltd. (HKSE:2607; Shanghai:601607) for an enterprise value of $1.2 billion, or $557 million in cash after excluding debt and...
22:30 , Jul 21, 2017 |  BC Extra  |  Company News

Cardinal seeking buyer for China distribution business

In a statement , Cardinal Health Inc. (NYSE:CAH) said it has "begun to explore strategic alternatives to support its next stage of growth" for its Cardinal Health China distribution business. The statement followed media reports...
01:07 , Dec 10, 2016 |  BC Extra  |  Company News

Management tracks

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said Deborah Waterhouse will succeed Dominique Limet at CEO of Viiv Heathcare, its HIV-focused joint venture with Pfizer Inc. (NYSE:PFE) and Shionogi & Co. Ltd. (Tokyo:4507). Limet is to step down...
21:05 , Dec 2, 2016 |  BC Week In Review  |  Company News

Navidea, Cardinal Health deal

Navidea will sell its Lymphoseek tilmanocept imaging agent to Cardinal Health for oncology indications for $80 million up front and up to $230 million in annual earn-out and sales milestone payments. Prior to the deal,...
07:00 , Oct 26, 2015 |  BC Week In Review  |  Company News

J&J, Cardinal Health deal

Cardinal completed its acquisition of Johnson & Johnson’s Cordis cardiology and endovascular device company for $1.9 billion in cash (see BioCentury, March 16). Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J.   Cardinal Health Inc. (NYSE:CAH),...
07:00 , Mar 16, 2015 |  BC Week In Review  |  Company News

J&J, Cardinal Health deal

Johnson & Johnson’s Ethicon Inc. subsidiary will sell its Cordis cardiology and endovascular devices company to Cardinal Health for $1.9 billion in cash. Cardinal expects the purchase to be accretive in 2017. The transaction is...
08:00 , Jan 12, 2015 |  BioCentury  |  Finance

Buyside view XXIII: Milestones galore

Stephen Hansen, Associate Editor and Jennifer Rhodes, Staff Writer   Buyside view XXIII The maturation of the biotech sector over the past few years finds fund managers focusing on a slew of clinical milestones and...